Published in Ophthalmologica on March 13, 2001
[Differential eyelid tumors diagnosis. II]. Ophthalmologe (2002) 0.87
[Therapy options for malignant eyelid tumors]. Ophthalmologe (2016) 0.75
Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts. Exp Eye Res (2008) 1.85
Silicone oil-associated optic nerve degeneration. Am J Ophthalmol (2001) 1.44
Aggressive metastasising adenocarcinoma of the retinal pigment epithelium with trisomy 21. Br J Ophthalmol (2008) 1.39
[Immune reactions after DMEK, DSAEK and DALK]. Klin Monbl Augenheilkd (2013) 1.34
[Current aspects of eyelid, lacrimal and orbital surgery in childhood]. Ophthalmologe (2015) 1.32
Epithelial transformation of the corneal endothelium in forceps birth-injury-associated keratopathy. Cornea (1993) 1.19
[Differential eyelid tumor diagnosis. I]. Ophthalmologe (2002) 1.16
[Selective lacrimal sac biopsy for external dacryocystorhinostomy: a clinical pathological study]. Ophthalmologe (2010) 1.12
[Corneal crosslinking: "Safe and effective"?]. Ophthalmologe (2009) 1.10
Clinicopathological review of 1146 enucleations (1980-90). Br J Ophthalmol (1994) 0.99
Corneal stromal calcification after topical steroid-phosphate therapy. Arch Ophthalmol (1999) 0.99
Ocular findings in ichthyosis follicularis, atrichia, and photophobia syndrome. Arch Ophthalmol (1999) 0.98
[Pilomatrixoma of the eyelids--clinical differential diagnosis and follow-up. Report of 17 patients]. Ophthalmologe (1993) 0.97
[Fungal keratitis with annular infiltration and hypopyon]. J Fr Ophtalmol (1993) 0.96
Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation. Br J Ophthalmol (2009) 0.96
[Malignant melanoma of the lacrimal sac]. Ophthalmologe (2008) 0.95
Orbital involvement in cherubism. Ophthalmology (2001) 0.95
Orbital lymphangioma with positive immunohistochemistry of lymphatic endothelial markers (vascular endothelial growth factor receptor 3 and podoplanin). Graefes Arch Clin Exp Ophthalmol (2001) 0.95
[Inhibition of angiogenesis in the anterior chamber of the eye]. Ophthalmologe (2007) 0.94
Clinical-pathologic correlation in Coats' disease. Graefes Arch Clin Exp Ophthalmol (2001) 0.93
[Conservative and surgical treatment of neurotrophic keratopathy]. Ophthalmologe (2005) 0.93
[Classification of ocular surface disease. Part 1]. Ophthalmologe (2003) 0.92
Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome: clinical and neuropathological observations in a 33-year-old man. Am J Med Genet (1998) 0.91
Hertel exophthalmometry versus computed tomography and optical 3D imaging for the determination of the globe position in zygomatic fractures. Int J Oral Maxillofac Surg (2004) 0.91
Different genetic pathways in the development of periocular sebaceous gland carcinomas in presumptive Muir-Torre syndrome patients. Hum Mutat (2006) 0.90
[Acute glaucoma: first manifestation of malignant melanoma of the choroid]. J Fr Ophtalmol (1993) 0.90
Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis. Exp Eye Res (2008) 0.89
Adenoma of the nonpigmented ciliary epithelium mimicking a malignant melanoma of the iris. Arch Ophthalmol (1999) 0.89
[Differential diagnosis and prognosis of 112 excised epibulbar epithelial tumors]. Klin Monbl Augenheilkd (1995) 0.88
Surgery for primary basal cell carcinoma including the eyelid margins with intraoperative frozen section control: comparative interventional study with a minimum clinical follow up of 5 years. Br J Ophthalmol (2004) 0.87
[Topical inhibition of angiogenesis at the cornea. Safety and efficacy]. Ophthalmologe (2009) 0.87
Primary intraosseous cavernous hemangioma of the orbit. Am J Ophthalmol (2001) 0.87
Deletions of BRCA1/2 and p53 R248W gain-of-function mutation suggest impaired homologous recombination repair in fragile histidine triad-negative sebaceous gland carcinomas. Br J Dermatol (2008) 0.87
Surgery of the cornea: corneal, limbal stem cell and amniotic membrane transplantation. Dev Ophthalmol (2008) 0.87
Recurrent macular corneal dystrophy type II 49 years after penetrating keratoplasty. Arch Ophthalmol (1999) 0.86
Oculocerebral non-Hodgkin's lymphoma with uveal involvement: development of an epibulbar tumor after vitrectomy. Arch Ophthalmol (2000) 0.86
[Synopsis of various electrophysiological tests in early glaucoma diagnosis--temporal and spatiotemporal contrast sensitivity, light- and color-contrast pattern-reversal electroretinogram, blue-yellow VEP]. Klin Monbl Augenheilkd (2000) 0.85
[DALK and penetrating laser keratoplasty for advanced keratoconus]. Ophthalmologe (2013) 0.84
[Clinical aspects and treatment of immune reactions following penetrating normal-risk keratoplasty]. Klin Monbl Augenheilkd (2004) 0.84
[Transitory intrathoracic and -abdominal pressure elevation in the history of 64 patients with normal pressure glaucoma]. Klin Monbl Augenheilkd (2001) 0.84
[Anti-inflammatory treatment in dry eye disease]. Klin Monbl Augenheilkd (2012) 0.83
[Research activities of medical students in Germany using as an example the Würzburg University Clinic]. Dtsch Med Wochenschr (1998) 0.83
Persisting retinal ganglion cell axons in blind atrophic human eyes. Graefes Arch Clin Exp Ophthalmol (2001) 0.83
Cutaneous angiosarcoma of the eyelids. Br J Ophthalmol (2003) 0.83
[Patient satisfaction after posterior lamellar keratoplasty (DSAEK)]. Klin Monbl Augenheilkd (2008) 0.82
Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas. Br J Dermatol (2006) 0.82
[Conjunctival myxoma. Apropos of an anatomo-clinical case]. J Fr Ophtalmol (1995) 0.82
[The dry eye. Current concepts on classification, diagnostics, and pathogenesis]. Ophthalmologe (2006) 0.82
[Immunological graft reactions after penetrating keratoplasty - A prospective randomized trial comparing corneal excimer laser and motor trephination]. Klin Monbl Augenheilkd (2001) 0.82
Changes in donor corneal lenticule thickness after Descemet's stripping automated endothelial keratoplasty (DSAEK) with organ-cultured corneas. Br J Ophthalmol (2009) 0.81
Sympathetic ophthalmia after three pars plana vitrectomies without prior ocular injury. Retina (2000) 0.81
Merkel cell carcinoma: clinicopathologic correlation, management, and follow-up in five patients. Ophthal Plast Reconstr Surg (2000) 0.81
[Epithelial giant inclusion cyst 50 years after enucleation without orbital implant]. Klin Monbl Augenheilkd (1998) 0.81
[Complications after posterior lamellar keratoplasty (DSAEK): prevention, detection and treatment]. Klin Monbl Augenheilkd (2010) 0.81
[Significance of transcanalicular laser assisted dacryocystorhinostomy in modern lacrimal drainage surgery]. Ophthalmologe (2015) 0.81
[Congenital divided compound nevi of the eyelids]. Klin Monbl Augenheilkd (1999) 0.80
[Pseudorheumatoid nodules of the eyelids (granuloma annulare of the nodular type)]. Klin Monbl Augenheilkd (1996) 0.80
[Operative techniques for surgical treatment of primary and recurrent pterygia]. Ophthalmologe (2010) 0.80
[Pediatric corneal surgery and corneal transplantation]. Ophthalmologe (2015) 0.80
[Eyelid tumor as a recurrence of a gastric MALT-lymphoma]. Klin Monbl Augenheilkd (2000) 0.80
[Molluscum contagiosum in immunosuppression with methotrexate: multiple warts with central depressions of the eyelids]. Klin Monbl Augenheilkd (1998) 0.80
Blood-aqueous barrier breakdown after penetrating keratoplasty with simultaneous extracapsular cataract extraction and posterior chamber lens implantation. Graefes Arch Clin Exp Ophthalmol (2001) 0.79
[Medial canthus pilomatrixoma in an 80-year-old patient]. Klin Monbl Augenheilkd (1993) 0.79
Management of spontaneous enophthalmos due to silent sinus syndrome: a case report. Int J Oral Maxillofac Surg (2005) 0.79
Bilateral cavernous degeneration of the optic nerve associated with multiple arteriosclerotic ischemic infarctions. Graefes Arch Clin Exp Ophthalmol (1993) 0.79
Multifocal corneal argyrosis after an explosion injury. Cornea (2001) 0.79
[Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops]. Ophthalmologe (2003) 0.79
[Split-cornea transplantation - a novel concept to reduce corneal donor shortage]. Klin Monbl Augenheilkd (2012) 0.79
[Manufacture of autologous serum eye drops for out-patient therapy : cooperation between ophthalmic clinic and transfusion medicine department]. Ophthalmologe (2008) 0.78
[Long-term outcome after penetrating keratoplasty for bullous keratopathy - influence of preoperative visual acuity on final outcome]. Klin Monbl Augenheilkd (2011) 0.78
Corpora amylacea in glaucomatous and non-glaucomatous optic nerve and retina. Graefes Arch Clin Exp Ophthalmol (1993) 0.78
[Pseudotumor of the cornea in childhood]. Ophthalmologe (2014) 0.78
[Palpebral nodule with focal madarosis: neoplasm or chalazion? Apropos of a case]. J Fr Ophtalmol (1993) 0.78
[Long-term outcome after penetrating keratoplasty for keratoconus--impact of preoperative corneal curvature and best corrected visual acuity on the functional results]. Klin Monbl Augenheilkd (2010) 0.78
[Epiphora with pressure-indolent swelling of the medial canthus]. Ophthalmologe (2014) 0.78
[Topical cyclosporine A 0.05% in the treatment of keratoconjunctivitis sicca]. Klin Monbl Augenheilkd (2011) 0.78
[Inflammation of the eye in systemic inflammatory disorders: keratitis]. Klin Monbl Augenheilkd (2011) 0.78
[Conjunctival balloon cell nevi--light- and electronmicroscopic findings in 2 patients]. Klin Monbl Augenheilkd (2001) 0.77
[Screening questionnaire for documentation of medical history and diagnostic findings in dry eye disease]. Klin Monbl Augenheilkd (2010) 0.77
[Histopathology of retrocorneal membranes after keratoplasty]. Klin Monbl Augenheilkd (2010) 0.77
Tumour-associated lymphangiogenesis in conjunctival malignant melanoma. Br J Ophthalmol (2009) 0.77
[Current treatment options with artificial corneas: Boston Kpro, Osteo-odontokeratoprosthesis, Miro Cornea® and KeraKlear®]. Ophthalmologe (2014) 0.77
[Topical application of EGF for the therapy of persisting corneal erosion under cetuximab treatment]. Ophthalmologe (2008) 0.77
[Decellularized collagen matrix from tilapia fish scales for corneal reconstruction (BioCornea)]. Ophthalmologe (2014) 0.77
[Endothelial immune reactions in times of lamellar corneal transplant surgery: mission completed?]. Klin Monbl Augenheilkd (2013) 0.76
[Epiphora and conjunctivitis for 6 years]. Ophthalmologe (2004) 0.76
[Late complications after chemical burns of the ocular surface. Surgical strategies for ocular surface reconstruction]. Ophthalmologe (2011) 0.76
[Antiangiogenic therapy at the ocular surface: when, what and why?]. Ophthalmologe (2011) 0.76
[Ophthalmological complications in Sjögren's syndrome]. Z Rheumatol (2010) 0.76
[Pterygium. Etiology, clinical aspects and novel adjuvant therapies]. Ophthalmologe (2010) 0.76
[Nodular fasciitis of the eyelid and anterior orbit in children: case report and review of the literature]. Ophthalmologe (2009) 0.75
[Visual rehabilitation and intraocular pressure elevation due to immunological graft rejection following penetrating keratoplasty]. Klin Monbl Augenheilkd (2001) 0.75
Amniotic membrane-covered bio-onlays for treatment of ocular surface disease. Br J Ophthalmol (2007) 0.75
Two-step retrograde closed stenting: a novel method for treating canalicular lacerations in Chinese patients. Eye (Lond) (2013) 0.75
Regression of mature lymphatic vessels in the cornea by photodynamic therapy. Br J Ophthalmol (2014) 0.75
[Retained Descemet's membrane after penetrating keratoplasty for macular corneal dystrophy]. Ophthalmologe (2010) 0.75